Boeynaems S et al.Phase Separation of C9orf72 Dipeptide Repeats Perturbs Stress Granule Dynamics.Mol Cell 65:1044-1055.e5 (2017).
Wang W et al.Antimicrobial peptide LL-37 promotes the viability and invasion of skin squamous cell carcinoma by upregulating YB-1.Exp Ther Med 14:499-506 (2017).
Shen H et al.Lin28A activates androgen receptor via regulation of c-myc and promotes malignancy of ER-/Her2+ breast cancer.Oncotarget 7:60407-60418 (2016).
Li Y et al.Investigation of the HIV-1 matrix interactome during virus replication.Proteomics Clin Appl 10:156-63 (2016).
Liu J et al.Long noncoding RNA POU6F2-AS2 is associated with oesophageal squamous cell carcinoma.J Biochem 160:195-204 (2016).
Imada K et al.FOXO3a Expression Regulated by ERK Signaling is Inversely Correlated With Y-Box Binding Protein-1 Expression in Prostate Cancer.Prostate N/A:N/A (2016).
Diaz-Lagares A et al.Epigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.Proc Natl Acad Sci U S A 113:E7535-E7544 (2016).
WB, IP, ICC/IF
Wang T et al.Pathogenic Mutations in the Valosin-containing Protein/p97(VCP) N-domain Inhibit the SUMOylation of VCP and Lead to Impaired Stress Response.J Biol Chem 291:14373-84 (2016).
Dey A et al.YB-1 is elevated in medulloblastoma and drives proliferation in Sonic hedgehog-dependent cerebellar granule neuron progenitor cells and medulloblastoma cells.Oncogene 35:4256-68 (2016).
Liu Y et al.lncRNA GAS5 enhances G1 cell cycle arrest via binding to YBX1 to regulate p21 expression in stomach cancer.Sci Rep 5:10159 (2015).
Satkunanathan S et al.Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy.Hum Gene Ther 25:929-41 (2014).
Imada K et al.Mutual regulation between Raf/MEK/ERK signaling and Y-box-binding protein-1 promotes prostate cancer progression.Clin Cancer Res 19:4638-50 (2013).
Xie W et al.Expression of Y-Box-binding protein 1 in Chinese patients with breast cancer.Tumour Biol 33:63-71 (2012).
Shiota M et al.Foxo3a suppression of urothelial cancer invasiveness through Twist1, Y-box-binding protein 1, and E-cadherin regulation.Clin Cancer Res 16:5654-63 (2010).